← All Sponsors
SPONSOR

Arbutus Biopharma Corporation

Total Trials
1
Recruiting
1
Phases
N/A
Conditions studied: Long Term Follow-up
NCT06277037
Recruiting

Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)

Long Term Follow-up
United States, Australia, Hong Kong View Trial →